NCT00132444View on ClinicalTrials.gov

Study of UC-781 Vaginal Microbicide

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
HIV Infections
Interventions
DRUG

topical vaginal application of UC-781 gel

UC-781 gel (arms 1 and 2) or placebo (arm 3) applied vaginally twice daily for 14 days

Trial Locations (1)

30030

Hope Clinic of Emory University, Decatur

All Listed Sponsors
collaborator

Emory University

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

CONRAD

OTHER

NCT00132444 - Study of UC-781 Vaginal Microbicide | Biotech Hunter | Biotech Hunter